Down-regulation of EGFL8: A novel biomarker for advanced gastric cancer

Anticancer Research

Volumn 31, Issue 10, 2011, Pages 3377-3380

  Wu, Fan ^a,b   Shirahata, Atsushi ^b   Sakuraba, Kazuma ^b   Kitamura, Yohei ^b   Goto, Tetsuhiro ^b   Saito, Mitsuo ^b   Ishibashi, Kazuyoshi ^b   Kigawa, Gaku ^b   Nemoto, Hiroshi ^b   Sanada, Yutaka ^b   Hibi, Kenji ^b  

^a JINAN UNIVERSITY   (China)

^b SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

EGFL8; Gastric cancer; Quantitative polymerase chain reaction

Indexed keywords

EPIDERMAL GROWTH FACTOR LIKE DOMAIN 8 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER;

AGED; DOWN-REGULATION; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 80054718841     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
2. Parkin DM, Pisani P and Ferlay J: Global cancer statistics. CA Cancer J Clin 49: 33-64, 1999. (Pubitemid 29094960)
3. Yasui W, Yokozaki H, Fujimoto J, Naka K, Kuniyasu H and Tahara E: Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. J Gastroenterol 35: 111-115, 2000. (Pubitemid 30229730)
4. Wu F, Shirahata A, Sakuraba K, Kitamura Y, Goto T, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y and Hibi K: Down-regulation of Mus81 as a potential marker for the malignancy of gastric cancer. Anticancer Res 30: 5011-5014, 2010.
5. Sakakibara T, Hibi K, Koike M, Fujiwara M, Kodera Y, Ito K and Nakao A: Plasminogen activator inhibitor-1 as a potential marker for the malignancy of gastric cancer. Cancer Sci 97: 395-399, 2006.
6. Hibi K, Sakata M, Sakuraba K, Kitamura YH, Shirahata A, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H and Sanada Y: Methylation of the DCC gene is lost in advanced gastric cancer. Anticancer Res 30: 107-109, 2010.
7. Sakata M, Kitamura YH, Sakuraba K, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y and Hibi K: Methylation of HACE1 in gastric carcinoma. Anticancer Res 29: 2231-2233, 2009.
8. Hibi K, Sakata M, Yokomizo K, Kitamura YH, Sakuraba K, Shirahata A, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H and Sanada Y: Methylation of the MGMT gene is frequently detected in advanced gastric carcinoma. Anticancer Res 29: 5053-5055, 2009.
9. Jankowski JA and Odze RD: Biomarkers in gastroenterology: between hope and hype comes histopathology. Am J Gastroenterol 104: 1093-1096, 2009.
10. Parker LH, Schmidt M, Jin SW, Gray AM, Beis D, Pham T, Frantz G, Palmieri S, Hillan K, Stainier DY, De Sauvage FJ and Ye W: The endothelial- cell-derived secreted factor Egfl7 regulates vascular tube formation. Nature 428: 754-758, 2004. (Pubitemid 38514720)
11. Wu F, Yang LY, Li YF, Ou DP, Chen DP and Fan C: Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma. Hepatology 50: 1839-1850, 2009.
12. Fitch MJ, Campagnolo L, Kuhnert F and Stuhlmann H: Egfl7, a novel epidermal growth factor-domain gene expressed in endothelial cells. Dev Dyn 230: 316-324, 2004. (Pubitemid 38669592)
13. Wu F, Shirahata A, Sakuraba K, Kitamura Y, Goto T, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y and Hibi K: Down-regulation of EGFL8: a novel prognostic biomarker for patients with colorectal cancer. Anticancer Res 31: 2249-2254, 2011.
14. Hibi K, Nakamura H, Hirai A Fujikake Y, Kasai Y, Akiyama S, Ito K and Takagi H: Loss of H19 imprinting in esophageal cancer. Cancer Res 56: 480-482, 1996. (Pubitemid 26048601)
15. Hibi K, Robinson CR, Booker S, Wu L, Hamilton SR, Sidransky D and Jen J: Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res 58: 1405-1407, 1998. (Pubitemid 28193600)
16. Saito Y, Friedman JM, Chihara Y, Egger G, Chuang JC and Liang G: Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem Biophys Res Commun 379: 726-731, 2009.
17. Le Bras A, Samson C, Trentini M, Caetano B, Lelievre E, Mattot V, Beermann F and Soncin F: VE-statin/egfl7 expression in endothelial cells is regulated by a distal enhancer and a proximal promoter under the direct control of Erg and GATA-2. PLoS One 5: e12156, 2010.
18. Sun Y, Bai Y, Zhang F, Wang Y, Guo Y and Guo L: miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7. Biochem Biophys Res Commun 391: 1483-1489, 2010.
19. Maleno I, Lopez Nevot MA, Seliger B and Garrido F: Low frequency of HLA haplotype loss associated with loss of heterozygocity in chromosome region 6p21 in clear renal cell carcinomas. Int J Cancer 109: 636-638, 2004. (Pubitemid 38344125)
20. Maleno I, Cabrera CM, Cabrera T, Paco L, López-Nevot MA, Collado A, Ferrón A and Garrido F: Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21. Immunogenetics 56: 244-253, 2004. (Pubitemid 39119279)
21. Wang XC, Zhang JQ, Shen YQ, Miao FQ and Xie W: Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer. J Exp Clin Cancer Res 25: 115-119, 2006.
22. Scartozzi M, Galizia E, Freddari F, Berardi R, Cellerino R and Cascinu S: Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches. Cancer Treat Rev 30: 451-459, 2004. (Pubitemid 38968125)
23. Nitti D, Mocellin S, Marchet A, Pilati P and Lise M: Recent advances in conventional and molecular prognostic factors for gastric carcinoma. Surg Oncol Clin N Am 17: 467-483, 2008. (Pubitemid 351672072)
24. Soncin F, Mattot V, Lionneton F, Sprayt N, Lepretre F, Begue A and Stehelin D: VE-statin, an endothelial repressor of smooth muscle cell migration. EMBO J 22: 5700-5711, 2003. (Pubitemid 37408810)
25. Carmeliet P: Angiogenesis in life, disease and medicine. Nature 438: 932-936, 2005.
26. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma, The 14th Edition. 2010.
27. Union for International Cancer Control: TNM Classification of malignant tumours, The 7th Edition. 2011.